I've asked IR for an update to the enrollment when they appeared to be late but I did not receive any information, since then of course they updated the expected end date to December. After that my research led me to believe that cycr is not to blame for the slow enrollment; getting women to return for a follow up exam and then signing up for the trial is. I have no doubt cycr will be the first to toot their horn as soon as they are done, or they will simply extend the completion date behind the scenes. I'm thinking 50/50 by the of March.
Having spain show interest in product development is a plus, cycr could use some help in getting things done. It's just that it could take another year before you hear of any progress in the AIPS and is not worth jumping on the bandwagon for, not right now anyway. You do realize the image on the cycr website is computer generated?! I mentioned before Monogen is already having their PMA reviewed for their automated slide system. This only puts more pressure on cycr to get things done ASAP. Whatever cycr does it always appears to be too little too late.
Yes PRVB they have agreements. The assumption going around is they may earn $1 per unit sold (sounds reasonable). With the current contracts that equates to 0.05 cents per share post split. A P/E of 100 makes that $5 post 1:10 RS. I'm not convinced the market will award this company such a high PE, not until they have shown the product is being adopted and selling well. Per usual we can only speculate on what they are actually earning on each item, it could be less. As I recall the handle alone costs almost $20 each to make and they may have to give these away at first to get doctors to try.
I am quite sure about one thing, they will continue to raise money to pay for their overhead by selling shares to other investors, diluting the float again. And it could be another year or two before you see positive earnings.
Why not wait until they have proven to be successful?
